Man

Miguel Reyes Parada

Full Professor

UNIVERSIDAD DE SANTIAGO DE CHILE, FACULTAD DE CIENCIAS MÉDICAS, ESCUELA DE MEDICINA

Santiago, Chile

Líneas de Investigación


Medicinal Chemistry, Pharmacology, Neuropharmacology, Polypharmacology

Educación

  •  Chemist and Pharmacist, UNIVERSIDAD DE CHILE. Chile, 1992
  •  Biological Sciences, Universidad de la República Oriental de Uruguay. Uruguay, 1996

Experiencia Académica

  •   Full professor Full Time

    UNIVERSIDAD DE SANTIAGO DE CHILE

    Ciencias Médicas

    Santiago, Chile

    1998 - At present

Experiencia Profesional

  •   Full Professor Full Time

    Universidad de Santiago de Chile

    Santiago, Chile

    1998 - At present

Formación de Capital Humano


- MSc. Thesis in Chemistry, University of Chile. “Synthesis, enantiomeric resolution and evaluation as MAO-inhibitors of 4-methylthio amphetamine and N-alkylated derivatives Claudio Hurtado-Guzmán. 2001.

- PhD. Thesis in Chemistry, University of Chile. “Synthesis of phenethylamine derivatives as potential MAO-inhibitors”. Alejandra Gallardo-Godoy. 2003.

- PhD. Thesis in Chemistry, University of Santiago de Chile. Quantitative structure-activity relationships of phenethylamine derivatives as potential MAO-inhibitors. Angélica Fierro. 2007

- PhD. Thesis in Biotechnology, University of Santiago de Chile. “Similarities between the binding sites of monoamine oxidase and the serotonin transporter: a study using mathematical algorithms, molecular simulation and biological assays”. Gabriel Núñez-Vivanco. 2015

- PhD. Thesis in Biotechnology, University of Santiago de Chile. “Determination of similarities between the active sites of monoaminergic proteins and nicotinic receptors: an approach for the rational design of polypharmacological drugs". Patricia Möller. 2017

- Dirección Investigacion PostDoctoral (financiamiento USACH), Rafael Barra 2012.

- Dirección Investigacion PostDoctoral (financiamiento USACH), Valeska Cid-Jofre 2024.

- Dirección Investigacion PostDoctoral (financiamiento ANID), Juan Pablo González-Gutiérrez En curso.



 

Article (106)

Parallel Algorithm for Discovering and Comparing Three-Dimensional Proteins Patterns
A New Strategy for Multitarget Drug Discovery/Repositioning Through the Identification of Similar 3D Amino Acid Patterns Among Proteins Structures: The Case of Tafluprost and its Effects on Cardiac Ion Channels
A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT<sub>1A</sub>Receptors
Constituents of <i>Cannabis sativa</i>
Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein beta gamma-Induced Dopamine Efflux
Amphetamine derivatives as monoamine oxidase inhibitors
Editorial: Celebrating 40 Years of the Chilean Society of Pharmacology
Nicotinic Antagonist UFR2709 Inhibits Nicotine Reward and Decreases Anxiety in Zebrafish
Pharmacological Characterization of 4-Methylthioamphetamine Derivatives
Synthesis, Docking, 3-D-Qsar, and Biological Assays of Novel Indole Derivatives Targeting Serotonin Transporter, Dopamine D2 Receptor, and Mao-A Enzyme: In the Pursuit for Potential Multitarget Directed Ligands
Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
3D-PP: A Tool for Discovering Conserved Three-Dimensional Protein Patterns
Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening
Facts and hypotheses about the programming of neuroplastic deficits by prenatal malnutrition.
Minimal Structural Changes Determine Full and Partial Nicotinic Receptor Agonist Activity for Nicotine Analogues
Synthesis of Novel Nicotinic Ligands with Multimodal Action: Targeting Acetylcholine alpha 4 beta 2, Dopamine and Serotonin Transporters
Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases
UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats
Vasopressin in the lateral septum decreases conditioned place preference to amphetamine and nucleus accumbens dopamine release
3D similarities between the binding sites of monoaminergic target proteins
Neonatal programming with testosterone propionate reduces dopamine transporter expression in nucleus accumbens and methylphenidate-induced locomotor activity in adult female rats
Characterization of a Novel Drosophila SERT Mutant: Insights on the Contribution of the Serotonin Neural System to Behaviors
Synthesis and Docking of Novel 3-Indolylpropyl Derivatives as New Polypharmacological Agents Displaying Affinity for 5-HT1AR/SERT
Geomfinder: a multi-feature identifier of similar three-dimensional protein patterns: a ligand-independent approach
Geomfinder: a multi-feature identifier of similar three-dimensional protein patterns: a ligand-independent approach.
The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors
The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy.
Similarities between the Binding Sites of SB-206553 at Serotonin Type 2 and Alpha7 Acetylcholine Nicotinic Receptors: Rationale for Its Polypharmacological Profile
Similarities between the Binding Sites of SB-206553 at Serotonin Type 2 and Alpha7 Acetylcholine Nicotinic Receptors: Rationale for Its Polypharmacological Profile
Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors
Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors
Improving Amphetamine Therapeutic Selectivity: N,N-dimethyl-MTA has Dopaminergic Effects and does not Produce Aortic Contraction
Improving Amphetamine Therapeutic Selectivity: N,N-dimethyl-MTA has Dopaminergic Effects and does not Produce Aortic Contraction
Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor
Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor
4-Methylthioamphetamine Increases Dopamine in the Rat Striatum and has Rewarding Effects In Vivo
4-Methylthioamphetamine Increases Dopamine in the Rat Striatum and has Rewarding Effects In Vivo
Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism
Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism
Synthesis, 5-hydroxytryptamine 1A receptor affinity and docking studies of 3-[3-(4-aryl-1-piperazinyl)-propyl]-1H-indole derivatives
Synthesis, 5-Hydroxytryptamine(1A) Receptor Affinity and Docking Studies of 3-[3-(4-Aryl-1-piperazinyl)-propyl]-1H-Indole Derivatives
Synthesis, 5-Hydroxytryptamine(1A) Receptor Affinity and Docking Studies of 3-[3-(4-Aryl-1-piperazinyl)-propyl]-1H-Indole Derivatives
Hacia nuevos modelos de enseñanza- aprendizaje en ciencias de la salud
Implementación y evaluación de una metodología de autoaprendizaje dirigido, para estudiantes de dos carreras de ciencias de la salud.
Polyphosphate synthesis as a target for novel antibiotics
Polyphosphate synthesis as a target for novel antibiotics.
2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors
2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors.
MDMA ("ecstasy") impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats
MDMA ("ecstasy") impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats.
Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors
Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors.
N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents
N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.
Prenatal to Early Postnatal Nicotine Exposure Impairs Central Chemoreception and Modifies Breathing Pattern in Mouse Neonates: A Probable Link to Sudden Infant Death Syndrome
Prenatal to early postnatal nicotine exposure impairs central chemoreception and modifies breathing pattern in mouse neonates: a probable link to sudden infant death syndrome.
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)(2A) and 5-HT2C receptors
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: Insights from molecular modeling studies
Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies.
Changes in antioxidant capacity of Tannat red wines during early maturation
Heteroarylisopropylamines as MAO inhibitors
Heteroarylisopropylamines as MAO inhibitors.
Monoamine Oxidase Inhibition In the Light of New Structural Data
Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: Biological activities, CoMFA analysis, and active site modeling
Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
"Delayed early morning turn ""ON"" in response to a single dose of levodopa in advanced Parkinson's disease: Pharmacokinetics should be considered [1]"
Delayed early morning turn "ON" in response to a single dose of levodopa in advanced Parkinson's disease: pharmacokinetics should be considered.
[Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study].
Comparación farmacocinética de Sinemetây Grifoparkinâ (levodopa/carbidopa 250/25 mg) en pacientes con enfermedad de Parkinson avanzada: un estudio con dosis única
Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine
Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine.
Pharmacokinetic comparison of Sinemet (R) and Grifoparkin (R) (levodopa/carbidopa) in Parkinson's disease: a single dose study
Pharmacokinetic comparison of Sinemet® and Grifoparkin® (levodopa/carbidopa) in Parkinson's disease: A single dose study Comparación farmacocinética de Sinemet® y Grifoparkin® (levodopa/carbidopa 250/25 mg) en pacientes con enfermedad de Parkinson avanzada: Un estudio con dosis única
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Heterogeneous catalysts in the preparation of 2-aryl-1,3-dinitropropanes from ?-nitrostyrenes or benzaldehydes
Heterogeneous catalysts in the preparation of 2-aryl-1,3-dinitropropanes from beta-nitrostyrenes or benzaldehydes
ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT(2a) and 5-HT(2c) receptor agonist
ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist
ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist.
Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission
Dopaminergic pharmacology and antioxidant properties of pukateine, a natural product lead for the design of agents increasing dopamine neurotransmission.
Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action
Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action.
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
Aggressive behavior and jamming avoidance response in the weakly electric fish Gymnotus carapo: Effects of 3,4-methylenedioxymethamphetamine (MDMA)
Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives. Structure-activity relationships
Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships.
(+/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors.
(±)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors
Behavioral effects of the putative anxiolytic (+/-)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice.
Behavioral effects of the putative anxiolytic (±)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice
Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
Sleep and waking in 5,7-DHT-lesioned or (−)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone
4-Dimethylaminophenethylamine, a sensitive, specific, electrochemically detectable monoamine oxidase-B substrate
4-Dimethylaminophenethylamine, a sensitive, specific, electrochemically detectable monoamine oxidase-B substrate.
Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat
Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat.
Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives
Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives.
Serotonergic control of electric organ discharge in Gymnotus carapo. Role of 5-HT2A/2c receptor subtypes
Preliminary voltametric data for the oxidation of 4-methylaminophenethylamine derivatives in buffer and in aprotic solvents
CRYSTAL STRUCTURE OF (E)-1-(4-DIMETHYLAMINOPHENYL)-2-NITROPROPENE

Abstract (6)

Crystal structure of potassium antimony hexathiodiphosphate, KSbP2S6
Hallucinogenic amphetamines and phenethylamines have different pharmacological profiles: in vitro and in vivo studies
New hypothesis for the role of 5-HT transporter in the effect of amphetamine derivatives in synaptosomes
N-substituted derivatives of the serotonin releaser MTA are potent MAO-A inhibitors.
Pharmacodynamics of ALEPH-2, in serotonergic models: novel properties of a modified phenylethylamine
The human retina during the embryonic period: a scanning electron microscopy study

BookSection (3)

Neuroprotection by the cannabis-related products, cannabidiol and cannabigerol, and their associated mechanisms of action
Targeting Alzheimer’s disease through Pharmacoinformatics: New Challenges in Drug Design.
Similarities between the binding sites of monoamine oxidase (MAO) from different species. Is zebrafish a useful model for the discovery of novel MAO inhibitors?

EditorialMaterial (1)

Delayed early morning turn ON'' in response to a single dose of levodopa in advanced Parkinson's disease: pharmacokinetics should be considered"

Proyecto (19)

Multisteric drugs: Design of polypharmacological agents that simultaneously interact with monoaminergic proteins and nicotinic receptors, based on similarities between their multiple binding sites
Multisteric drugs=> Design of polypharmacological agents that simultaneously interact with monoaminergic proteins and nicotinic receptors, based on similarities between their multiple binding sites
Synthesis of Novel Indole Derivatives Targeting=> Serotonergic (SERT inhibition /5-HT4 Agonist Activity), Cholinergic (Acetylcholinesterase Inhibition) and &#946;-Amyloid Deposition, in the Search of Multifunctional Agents in Alzheimer´s Disease
“Synthesis of Novel Indole Derivatives Targeting: Serotonergic (SERT inhibition /5 HT4 Agonist Activity), Cholinergic (Acetylcholinesterase Inhibition) and β-Amyloid Deposition, in the Search of Multifunctional Agents in Alzheimer´s Disease
Designing chemical poly-bullets for nicotinic acetylcholine receptors and monoamine transporters (SERT, NET and DAT). A poly- pharmacology approach to understand the nicotine addiction and withdrawal syndrome mediated by multiple receptor targets.
DESIGNING CHEMICAL POLY-BULLETS FOR NICOTINIC ACETYLCHOLINE RECEPTORS AND MONOAMINE TRANSPORTERS (SERT, NET AND DAT). A POLY-PHARMACOLOGY APPROACH TO UNDERSTAND THE NICOTINE ADDICTION AND WITHDRAWAL SYNDROME MEDIATED BY MULTIPLE RECEPT
A synthetic approach towards novel series of 3-(3-(1-piperazinyl)propyl-1h-indole derivatives as monoaminergic multi-target agents. Docking studies and pharmacological evaluation at SERT, D2 and MAO-A receptors
A synthetic approach towards novel series of 3-(3-(1-piperazinyl)propyl-1h-indole derivatives as monoaminergic multi-target agents. Docking studies and pharmacological evaluation at SERT, D2 and MAO-A receptors
Fishing for complements: Design of compounds that simultaneously interact with monoaminergic proteins and nicotinic receptors, based on similarities between their ligand binding sites
Fishing for complements=> Design of compounds that simultaneously interact with monoaminergic proteins and nicotinic receptors, based on similarities between their ligand binding sites”
Design, Synthesis and Pharmacological Evaluation of Dual Nicotinic Agonist and MAO-B Inhibitors Activity for Regulation of Dopamine Level in the Brain
Design, Synthesis and Pharmacological Evaluation of Dual Nicotinic Agonist and MAO-B Inhibitors Activity for Regulation of Dopamine Level in the Brain.
A Rational Synthetic Approach to 3-Indolealkyl(Aryl)Piperazine Derivatives as New Hetero and Homobivalent Ligands With Potential Serotonergic Activity
A Rational Synthetic Approach to 3-Indolealkyl(Aryl)Piperazine Derivatives as New Hetero and Homobivalent Ligands With Potential Serotonergic Activity
The Monoaminergic "Receptophore". Similarities Among the Active Sites of Monoaminergic Target Proteins, Based on their Crystal Structures: Implications for the Development of Selective and Non-Selective Ligands
The Monoaminergic "Receptophore". Similarities Among the Active Sites of Monoaminergic Target Proteins, Based on their Crystal Structures=> Implications for the Development of Selective and Non-Selective Ligands.
Monoamine Oxidase Inhibitors. Binding Mode, Rational Design, Synthesis and Pharmacological Evaluation Based on the Enzymes Crystal Structures
Monoamine Oxidase Inhibitors. Binding Mode, Rational Design, Synthesis and Pharmacological Evaluation Based on the Enzymes Crystal Structures
Phenethylamine as probes for exploring the MAO active site

Review (4)

Psychostimulants and social behaviors
Role of Oxytocin and Vasopressin in Neuropsychiatric Disorders: Therapeutic Potential of Agonists and Antagonists
Facts and hypotheses about the programming of neuroplastic deficits by prenatal malnutrition
Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy
95
Miguel Reyes

Full Professor

Facultad de Ciencias Médicas

UNIVERSIDAD DE SANTIAGO DE CHILE, FACULTAD DE CIENCIAS MÉDICAS, ESCUELA DE MEDICINA

Santiago, Chile

11
Angelica Fierro

Associate

Chemistry

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

9
Ramón Sotomayor

Full Professor

Institute of Physiology

UNIVERSIDAD DE VALPARAÍSO, FACULTAD DE CIENCIAS, DEPARTAMENTO DE FISIOLOGÍA

Valparaíso, Chile

8
Bruce Cassels

Profesor Titular

Departamento de Química

UNIVERSIDAD DE CHILE, FACULTAD DE CIENCIAS, DEPARTAMENTO DE QUÍMICA

Santiago, Chile

8
Gabriel Nuñez

Jefe de Carrera, Ingeniería Civil Informática

Ciencias Naturales y Tecnología

Universidad de Aysén

Coyhaique, Chile

6
Patricio Iturriaga

Profesor Asociado A

Ciencias Quimicas y Recursos Naturales

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

5
Ramiro Araya Maturana

Profesor Titular

Universidad de Talca

SantiaTalcago, Chile

4
Pablo Moya

Full Professor

Instituto de Fisiología

Universidad de Valparaiso

Valparaiso, Chile

4
Gerald Zapata

Profesor Asociado

Química Inorgánica y Analítica

Universidad de Chile

Santiago, Chile

4
Katia Gysling

Professor

Cellular and Molecular Biology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

3
JAIME MELLA

PROFESOR ADJUNTO

INSTITUTO DE QUIMICA Y BIOQUIMICA

UNIVERSIDAD DE VALPARAISO

VALPARAISO, Chile

3
Pedro Chana Cuevas

Profesor Titular

Facultad de Ciencias Medicas

Universidad de Santiago

Santiago, Chile

2
Sebastián Loyola

Académico Investigador

Ciencias de la Salud

Universidad Católica Silva Henriquez

Santiago, Chile

2
Rommy von Bernhardi

Full Professor

Neurology

DEPT. NEUROLOGY, FAC. MEDICINE PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Floria Pancetti

Director de Departamento

Ciencias Biomédicas

UNIVERSIDAD CATOLICA DEL NORTE

Coquimbo, Chile

2
Susan Lühr

Profesor Asistente

Química

Universidad de Chile

Santiago, Chile

2
HERNAN PESSOA

Profesor Asociado

Química Orgánica y Fisicoquímica

UNIVERSIDAD DE CHILE

SANTIAGO, Chile

2
Carlos Pessoa

Profesor Titular

Departamento de Farmacia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Bernardo Morales

Profesor titular

Biologia

Universidad de Santiago de Chile

Santiago, Chile

2
Claudio Acuña

Profesosr Asociado

Biología

UNIVERSIDAD DE SANTIAGO DE CHILE

Santiago, Chile

2
Paul Silva

Profesor

Química Orgánica y Fisicoquímica

Universidad de Chile

Santiago, Chile

2
David Ramirez

Profesor Asistente

Facultad de Ciencias Biológicas

Universidad de Concepción

Concepcion, Chile

1
Claudio Coddou

Profesor Asociado

Departamento de Ciencias Biomédicas

Universidad Católica del Norte

Coquimbo, Chile

1
Georgina Renard

Associate professor - Directora CIBAP

School of Medicine

Universidad de Santiago de Chile

Santiago, Chile

1
Leandro Zuñiga

Profesor Asociado

Medicine

Universidad de Talca

Talca, Chile

1
Julio Caballero

Full Professor

Departamento de Bioinformática

Universidad de Talca

Talca, Chile

1
Gonzalo Yévenes

Associate Professor

Universidad de Concepcion

Concepcion, Chile

1
Christopher Cerda

Profesor

Universidad Bernardo O'Higgins

Santiago, Chile

1
HECTOR BURGOS

INVESTIGADOR

FACULTAD DE CIENCIAS

UNIVERSIDAD SANTO TOMÁS, Chile

SANTIAGO, Chile

1
Ana Martinez

Research Professor

Centro Investigaciones Biológicas (CIB)

Consejo Superior de Investigaciones Científicas (CSIC)

Madrid, Chile

1
Jonathan Martínez

Profesor ayudante

UNIVERSIDAD DE VALPARAISO

Valparasiso, Chile

1
Oscar Forero

Investigador

Instituto de Química de Recursos Naturales

Universidad de Talca

Talca, Chile

1
EDWIN PÉREZ

Profesor Asociado

Departamento de Química Orgánica

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Cecilia Rojas

Asistente de investigación

Virologia Molecular y Celular

Universidad de Chile

Santiago, Chile

1
Cristian Salas

Associate professor

Organic Chemistry

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Jorge Campusano

Associate Professor

Cell & Molecular Biology

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Bárbara Arévalo

Investigador

Investigación

Centro de Estudios de Alimentos Procesados

Talca, Chile

1
Rafaella Zárate

Investigadora Postdoctoral

Instituto Antofagasta

Universidad de Antofagasta

Antofagasta, Chile

1
Felipe Moraga

Profesor a Contrata

Departamento de Ciencias Químicas y Recursos Naturales

Universidad de La Frontera

Temuco, Chile

1
Maria Forray

PROFESOR ASOCIADO

FARMACIA

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

1
Rodrigo Varas

Profesor Asociado

Universidad Autónoma de Chile

Talca, Chile

1
Macarena Gárate

Asistente de investigación

Centro de Investigación Biomédica Aplicada (CIBAP)

Universidad de Santiago de Chile

Santiago, Chile

1
Eduardo Bravo

University of Iowa

Iowa City, Estados Unidos

1
Daniela Beltran

MEDICO

MEDICINA INTERNA

Pontificia Universidad Católica de Chile

La Reina, Chile

1
José Pino

Jefe de Carrera Bioquímica

Ciencias

Universidad de Viña del Mar

Viña del Mar, Chile

1
CLAUDIO SAITZ

Associate Prof.

Organic and Phisycal Chemistry

UNIVERSIDAD DE CHILE-FAC. CS. QUIMICAS Y FARMACEUTICAS

Santiago, Chile

1
JORGE FUENTEALBA

Dean

Physiology

UNIVERISDAD DE CONCEPCION

Concepcion, Chile

1
Patricio Rojas

Assistant Professor

Departamento de Biologia

UNIVERSIDAD DE SANTIAGO DE CHILE

Santiago, Chile

1
Marc Zeise

UNIVERSIDAD DE SANTIAGO DE CHILE

Santiago, Chile

1
Gonzalo Ugarte

Asistente de Investigación

Biología

UNIVERSIDAD DE SANTIAGO DE CHILE

Santiago, Chile

1
Nelson Barrera

Associate Professor

Physiology

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Samuel Morales

Académico Conferenciante

Universidad de Talca

Talca, Chile

1
VICTORIA VELASQUEZ

PhD student

Fisiología

Universidad de Valparaíso

Valparaíso, Chile

1
rafael barra

Academico investigador

Escuela de Medicina

universidad de santiago de Chile

Santiago de Chile, Chile

1
Wendy Gonzalez

Director of the Center for Bioinformatics, Simulations and Modeling (CBSM)

Bioinformática

CENTRO DE BIOINFORMÁTICA Y SIMULACIÓN MOLECULAR (CBSM)/ UNIVERSIDAD DE TALCA

Talca, Chile

1
Guillermo Díaz

Académico

Química Farmacológica y Toxicológica

UNIVERSIDAD DE CHILE, FACULTAD DE CIENCIAS QUÍMICAS Y FARMACÉUTICAS

Santiago, Chile

1
Pablo Moya

Docente de apoyo

Kinesiología

Universidad de

Santiago, Chile

1
Fanny Guzman

Investigador Senior

Núcleo de Biotecnología Curauma

Pontificia Universidad Católica de Valparaiso

Valparaiso, Chile

1
Claudio Coddou

Profesor Asociado

Ciencias Biomédicas

Universidad Católica del Norte

Coquimbo, Chile

1
Jaime Eugenin

Full Professor

Biology

Universidad de Santiago de Chile

Santiago, Chile

1
Gabriel Vallejos

Académico

UNIVERSIDAD ASUTRAL DE CHILE

Valdivia, Chile

1
ANTONIO GALDAMEZ

ASSOCIATE PROFESSOR

CHEMISTRY

DEPARTAMENTO DE QUÍMICA, FACULTAD DE CIENCIA, UNIVERSIDAD DE CHILE

SANTIAGO, Chile

1
Maria Ibañez

DIRECTORA GENERAL DE INVESTIGACIÓN E INNOVACIÓN

UNIVERSIDAD DEL ALBA

Santiago, Chile